JAZZ · NASDAQ · Biotechnology

Jazz Pharmaceuticals (JAZZ)

Develops rare-disease medicines across sleep, epilepsy and oncology.

$241.09
vs last close−0.37 (−0.15%)
  1. Why Is Jazz (JAZZ) Down 6.9% Since Last Earnings Report?

    Zacks Investment ResearchMarket move